EPG Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $513K | Buy |
4,627
+89
| +2% | +$9.87K | 0.15% | 141 |
|
2025
Q1 | $509K | Sell |
4,538
-105
| -2% | -$11.8K | 0.14% | 163 |
|
2024
Q4 | $429K | Buy |
4,643
+28
| +0.6% | +$2.59K | 0.11% | 171 |
|
2024
Q3 | $387K | Buy |
+4,615
| New | +$387K | 0.1% | 178 |
|
2024
Q2 | – | Sell |
-5,082
| Closed | -$372K | – | 198 |
|
2024
Q1 | $372K | Buy |
5,082
+4
| +0.1% | +$293 | 0.09% | 195 |
|
2023
Q4 | $373K | Sell |
5,078
-582
| -10% | -$42.8K | 0.1% | 185 |
|
2023
Q3 | $424K | Sell |
5,660
-6,304
| -53% | -$472K | 0.13% | 159 |
|
2023
Q2 | $922K | Buy |
11,964
+184
| +2% | +$14.2K | 0.27% | 96 |
|
2023
Q1 | $977K | Buy |
+11,780
| New | +$977K | 0.31% | 84 |
|
2020
Q2 | – | Sell |
-410
| Closed | -$30K | – | 377 |
|
2020
Q1 | $30K | Buy |
410
+267
| +187% | +$19.5K | 0.02% | 340 |
|
2019
Q4 | $9K | Buy |
+143
| New | +$9K | 0.01% | 436 |
|